Trends and disparities in China's cardiovascular disease burden from 1990 to 2019

Jiale Zhang1, Hongxuan Tong1, Lijie Jiang1

  • 1Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Insights

Cardiovascular disease (CVD) prevalence in China has surged by 140% since 1990, with metabolic risks like high blood pressure being major contributors. Projections indicate a stabilization and decline in CVD burden by 2030.

Area of Science:

  • Epidemiology
  • Public Health
  • Cardiovascular Disease Research

Background:

  • Cardiovascular diseases (CVD) pose a significant public health challenge, necessitating systematic assessment of risk factors for effective prevention strategies.
  • Understanding long-term trends and epidemiological characteristics of CVD in China is crucial given its large and aging population.

Purpose of the Study:

  • To systematically assess the burden of cardiovascular diseases (CVD) in China using the Global Burden of Disease (GBD) 2019 study.
  • To analyze long-term trends, epidemiological characteristics, and attributable risk factors of CVD in the Chinese population.

Main Methods:

  • Comprehensive analysis of CVD burden metrics including prevalence, incidence, mortality, YLLs, YLDs, and DALYs using GBD 2019 data.
  • Application of joinpoint regression, age-period-cohort (APC) models, and Bayesian APC (BAPC) for trend analysis and mortality/morbidity prediction.
  • Investigation of CVD-attributable risk factors, with a focus on metabolic risks.

Main Results:

  • CVD prevalence in China reached 120 million in 2019, a 140.02% increase from 1990, with a 52.56% rise in CVD-attributed DALYs.
  • While incidence showed a fluctuating downward trend, mortality significantly declined. Recent generations exhibit higher prevalence, and prevalence is increasing within age groups.
  • BAPC predictions suggest CVD prevalence and mortality will stabilize and decline between 2020-2030, particularly in males. High blood pressure was identified as the primary metabolic risk factor.

Conclusions:

  • The substantial and increasing burden of CVD in China, exacerbated by an aging population, represents a major public health concern.
  • Urgent development and implementation of practical strategies for CVD prevention and management are essential to mitigate this growing health challenge.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
366
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K